Skip to the page

Data / Form D filings / ADIPO THERAPEUTICS, LLC

ADIPO THERAPEUTICS, LLC: Form D filings

ADIPO THERAPEUTICS, LLC, a biotechnology company in Indianapolis, IN, filed 2 Form D notices with the SEC between 2020 and 2024. The latest, on December 11, 2024, reports $4.7 million sold of a $14.7 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1210 Waterway Blvd., Indianapolis, IN, 46202
Phone
(434) 409-9135
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Indiana
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1823434

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 11, 2024New notice$14,717,337$4,717,337$10,000,00020Nov 19, 2024sec.gov
Sep 2, 2020New notice$2,000,000$1,250,000$750,0002Aug 18, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Keith JohnsExecutive Officer
Karen WursterExecutive Officer, Director
Meng DengDirector
Michael ClaymanDirector

Other biotechnology companies in Indiana that filed recently

Every Form D from the week of Dec 9, 2024 · All recent filings in Indiana · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what ADIPO THERAPEUTICS, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.